Law Daily Report

New Immunotherapy Approved for Advanced Melanoma Patients

  • 📰 Medscape
  • ⏱ Reading Time:
  • 5 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 55%

Health News

Immunotherapy,Melanoma,PD-1

The tumor-derived autologous T-cell immunotherapy has been approved for adult patients previously treated with a PD-1-blocking antibody. This therapy offers hope to advanced melanoma patients who have not responded to standard treatments. The approval was based on a clinical trial showing a 31.5% objective response rate.

The tumor-derived autologous T-cell immunotherapy has been approved for adult patients previously treated with a PD-1-blocking antibody. This therapy offers hope to advanced melanoma patients who have not responded to standard treatments.

The approval was based on a clinical trial showing a 31.5% objective response rate.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

A New Law Requires All Cosmetology Students in New York State Learn to Style Textured HairBill S6528A was signed by New York Gov. Kathy Hochul, making it required by law for aspiring hairstylists to be trained on natural curly and coily hair textures. Here's what that means for cosmetology schools.
Source: Allure_magazine - 🏆 473. / 51 Read more »